CAR-NK Cell Therapy: A Transformative Approach to Overcoming Oncological Challenges
Biomolecules · 20.08.2024 · 14 (8) · 1035
DOI: 10.3390/biom14081035 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 20.08.2024. Verfasst von Wangshu Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: China Key Laboratory for Early Diagnosis and Biotherapy of Malignant Tumors in Children and Women, Dalian Women and Children's Medical Group, Dalian …. Hauptthemen laut MEDLINE: Killer Cells, Natural, Neoplasms, Receptors, Chimeric Antigen, Immunotherapy, Adoptive. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dalian City Outstanding Young Science and Technology Talent Program, Dalian City High-Level Innovative Talent Team Project.
Abstract (Originalsprache)
The use of chimeric antigen receptor (CAR) in natural killer (NK) cells for cancer therapy is gaining momentum, marking a significant shift in cancer treatment. This review aims to explore the potential of CAR-NK cell therapy in cancer immunotherapy, providing a fresh perspective. It discusses the innovative approaches in CAR-NK cell design and engineering, particularly targeting refractory or recurrent cancers. By comparing CAR-NK cells with traditional therapies, the review highlights their unique ability to tackle tumor heterogeneity and immune system suppression. Additionally, it explains how novel cytokines and receptors can enhance CAR-NK cell efficacy, specificity, and functionality. This review underscores the advantages of CAR-NK cells, including reduced toxicity, lower cost, and broader accessibility compared to CAR-T cells, along with their potential in treating both blood cancers and solid tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- China Key Laboratory for Early Diagnosis and Biotherapy of Malignant Tumors in Children and Women, Dalian Women and Children's Medical Group, Dalian 116012, China.
- Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang 110004, China.
- The Second Affiliated Hospital of Harbin Medical University, Harbin 151801, China.
ORCID-Profile: Wangshu Li, Xu Zhang, Aziz Ur Rehman Aziz
Förderung
- Dalian City Outstanding Young Science and Technology Talent Program
- Dalian City High-Level Innovative Talent Team Project
Zitieren
APA
Li, W., Wang, X., Zhang, X., Aziz, A. U. R., & Wang, D. (2024). CAR-NK Cell Therapy: A Transformative Approach to Overcoming Oncological Challenges. Biomolecules, 14(8), 1035. https://doi.org/10.3390/biom14081035
Vancouver
Li W, Wang X, Zhang X, Aziz AUR, Wang D. CAR-NK Cell Therapy: A Transformative Approach to Overcoming Oncological Challenges. Biomolecules. 2024;14(8):1035. doi:10.3390/biom14081035
BibTeX
@article{Li2024,
author = {Li, Wangshu and Wang, Xiuying and Zhang, Xu and Aziz, Aziz Ur Rehman and Wang, Daqing},
title = {CAR-NK Cell Therapy: A Transformative Approach to Overcoming Oncological Challenges},
journal = {Biomolecules},
year = {2024},
volume = {14},
number = {8},
pages = {1035},
doi = {10.3390/biom14081035}
}
EUVIMED